ArticleScientific reports2024

Dual anti-HER2/EGFR inhibition synergistically increases therapeutic effects and alters tumor oxygenation in HNSCC.

Patrick N Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.